Astrid Pechmann

机构：University of Freiburg, University Medical Center Freiburg · ORCID：0000-0001-9579-2343

发表论文 109 篇 · 总被引 2484 次 · h-index 26

代表论文

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study (2023 · Muscle & Nerve · 被引 122)
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy (2022 · Brain · 被引 76)
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy (2024 · Archives of Pediatrics and Adolescent Medicine · 被引 74)
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment (2022 · European Journal of Neurology · 被引 69)
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study (2024 · The Lancet Regional Health - Europe · 被引 65)
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (2023 · Neurology and Therapy · 被引 55)